Skip to main content
BIOTRON LIMITED logo

BIOTRON LIMITED — Investor Relations & Filings

Ticker · BIT ISIN · AU000000BIT4 ASX Professional, scientific and technical activities
Open in API
Filings indexed 765 across all filing types
Latest filing 2018-07-10 Interim / Quarterly Rep…
Country AU Australia
Listing ASX BIT

About BIOTRON LIMITED

https://www.biotron.com.au

Biotron Limited is a clinical-stage company focused on the development of novel small molecule antiviral therapeutics. The company utilizes its proprietary ViroPore technology platform to design and develop drugs that target viroporins—a class of proteins found in a wide range of viruses that play critical roles in viral replication and the evasion of host immune responses. Biotron's primary clinical program centers on BIT225, a first-in-class inhibitor targeting the HIV-1 Vpu protein and the Hepatitis C virus p7 protein. The company aims to address unmet medical needs by developing treatments that can potentially eradicate viral reservoirs and improve patient outcomes. In addition to HIV and HCV, Biotron is exploring the application of its antiviral platform against other significant viral pathogens, including SARS-CoV-2, leveraging its expertise in ion channel-targeting chemistry to disrupt the viral life cycle.

Recent filings

Filing Released Lang Actions
Appendix 4C - quarterly 5 pages 701.4KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B' and contains detailed consolidated cash flow statements for the quarter ended 30 June 2018. It includes financial data such as cash flows from operating, investing, and financing activities, reconciliation of cash and cash equivalents, payments to directors and related parties, financing facilities, estimated cash outflows for the next quarter, and compliance statements. The document is approximately 8580 characters long, which is substantial and contains actual financial data and analysis for a quarterly period. The presence of detailed financial statements and notes indicates this is a comprehensive interim/quarterly financial report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2018-07-10 English
Appendix 3B 13 pages 914.0KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B - New Issue Announcement' and is addressed to ASX Limited, referencing Listing Rule 3.10. It contains detailed information about the issuance of new securities, including the class, number, issue price, purpose, and quotation application. The document is a formal announcement of a new share issue and application for quotation of additional securities on the Australian Securities Exchange (ASX). It does not contain financial statements, management discussion, or audit information, but rather focuses on the capital raising and share issuance process. This matches the definition of a Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement of a report publication but the actual filing of the new issue details.
2018-07-09 English
New Issue Announcement 14 pages 1.0MB
Capital/Financing Update Classification · 100% confidence The document is a detailed announcement regarding the allotment and issuance of new shares and attaching options under a Renounceable Rights Issue and a Share Placement Offer. It includes compliance statements under the Corporations Act, references to ASX Listing Rules, and an Appendix 3B form which is a standard form used in Australian securities markets for new issue announcements and applications for quotation of additional securities. The content focuses on the issuance of new securities, their terms, and regulatory compliance related to the capital raising event. There is no financial performance data, earnings information, or management discussion. The document is not a report but an official announcement of a capital raising event and new share issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2018-06-13 English
Change of Director's Interest Notice 9 pages 700.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references Listing Rule 3.19A.2, which pertains to changes in directors' interests in securities. It contains detailed disclosures of shareholdings and options acquired by directors, including dates, number of securities, and nature of the transactions. The document is a formal notification to the ASX (Australian Securities Exchange) about changes in directors' shareholdings. There is no financial performance data, earnings information, or management discussion. The content matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives. The document length is substantial and contains multiple such notices for different directors, confirming it is not a brief announcement but a detailed report of director dealings.
2018-06-13 English
New Issue Oversubscribed 1 page 295.4KB
Capital/Financing Update Classification · 95% confidence The document is a short letter dated 12 June 2018 from the company secretary to the ASX Limited, announcing that the company's offer of new securities has been oversubscribed. It references a Prospectus dated 10 May 2018 and an Appendix 3B - New Issue Announcement. The content focuses on the issuance of new shares and options, indicating a capital raising event. The document length is only 1265 characters, which is quite short and is an announcement rather than a detailed report. Therefore, this document fits the category of Capital/Financing Update (CAP), as it provides an update on the company's fundraising and capital structure changes.
2018-06-11 English
Appendix 3B 13 pages 835.8KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a New Issue Announcement and Application for Quotation of Additional Securities filed with the ASX (Australian Securities Exchange). It details the issuance of fully paid ordinary shares, exercise of options, and the calculation of placement capacity under ASX Listing Rules 7.1 and 7.1A. The document is regulatory in nature, providing detailed information about a new share issue and the application for quotation of these securities on the exchange. It is not a financial report, earnings release, or management discussion, but a formal announcement related to capital changes and securities issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2018-05-27 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.